We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 699

FDA schedules public hearing on solutions to drug shortages
  • Hogan Lovells
  • USA
  • October 8 2018

FDA schedules public hearing on solutions to drug shortages October 08, 2018 The U.S. Food and Drug Administration (FDA) has announced it will hold a


Senate Overwhelmingly Clears Bipartisan Opioid Package
  • Squire Patton Boggs
  • USA
  • September 24 2018

Nearly three months following House passage of a legislative proposal related to America’s opioid epidemic, the Senate overwhelmingly cleared its own


OIG’s First Audit of Open Payments Program: Compliance Rate High, but Data Needs Improvement
  • Hall Render Killian Heath & Lyman PC
  • USA
  • September 7 2018

Recently, the Department of Health and Human Services Office of Inspector General (“OIG”) released findings of an audit of the Centers for Medicare


CMS Allows Medicare Part D Indication-Based Formulary Design
  • Holland & Knight LLP
  • USA
  • August 30 2018

The Centers for Medicare and Medicaid Services (CMS) has just announced a significant shift in Medicare Part D formulary design to allow Part D


DOJ Announces Revised Opioid Anti-Diversion Policy
  • FisherBroyles LLP
  • USA
  • July 16 2018

Last week, the Department of Justice (DOJ) announced that it had finalized new rules to prevent the diversion of prescription opioids in a move


House Opioid Measure Frenzy Continues
  • Quarles & Brady LLP
  • USA
  • July 16 2018

Over a period of two weeks in June, the House passed several bills aimed at combating the ongoing opioid epidemic. Our summary of the earlier measures


Washington Healthcare Update - Jul 16, 2018
  • McGuireWoods LLP
  • USA
  • July 16 2018

In a two-day markup, the House Ways and Means Committee cleared a number of measures related to health savings accounts and a measure that would


U.S. House legislation highlights escalating government-wide focus on opioid abuse
  • Hogan Lovells
  • USA
  • July 6 2018

On June 22 the U.S. House of Representatives passed sweeping legislation that represents "the biggest effort Congress has ever undertaken" to address


Washington Healthcare Update - Jul 2, 2018
  • McGuireWoods LLP
  • USA
  • July 2 2018

House GOP appropriators have again postponed consideration of their Labor-HHS-Education spending bill. The markup, which had been rescheduled for


Washington Healthcare Update - Jun 18, 2018
  • McGuireWoods LLP
  • USA
  • June 18 2018

The House began its two-week vote-a-thon on opioid legislation. On June 12, the house passed 25 bills and continued to work on opioid legislation